Antares Pharma has announced via email, that it will no longer do business with the notorious contract animal research facility Huntingdon Life Sciences (HLS). This is just more bad news for the company that has recently lost several of it's major shareholders and is reportedly over 100 million dollars in debt. It's time to turn up the heat. Let 2008 be the year to smash HLS!
ANTARES PHARMA VOWS NOT TO USE HLS
"Antares Pharma does not and will not use any of the services of Huntington
Life Science (HLS) or its subsidiaries."
